HIV drugs News and Research

RSS

AIDS 2010 studies, releases: Criminalization, discrimination of high-risk groups; Test-and-treat; UNAIDS launches HIV prevention commission

The criminalization of men who have sex with men (MSM) and transgender people in Asia is holding back efforts to contain HIV/AIDS in the region, according to a report presented Wednesday by the U.N. Development Program (UNDP) and Asia Pacific Coalition on Male Sexual Health at the International AIDS Conference-AIDS 2010, VOA News reports. The report "linked the criminalization of homosexual behavior to an increase in the infection rate of HIV and AIDS in Asia," the news service writes (Dewan, 7/21).

23 Jul 2010

AIDS 2010: Halving HIV/TB co-infection deaths; Financial transaction tax discussed, and more

UNAIDS and the Stop TB Partnership joined together on Thursday at the International AIDS Conference-AIDS 2010 in Vienna, Austria, with the goal of preventing 200,000 deaths annually from HIV and tuberculosis co-infection, Agence France-Presse reports. TB is the number one killer of people living with HIV/AIDS (Ingham, 7/22).

23 Jul 2010

New HIV drug on the block

Johnson and Johnson’s experimental HIV drug rilpivirine or TMC278, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is being developed for use in combination therapy for treating the human immunodeficiency virus (HIV) that causes AIDS. Two clinical trials with the drug has shown that although its effectiveness was same as the existing anti-HIV drugs, its side effects were fewer. On the flip side nearly twice as many patients failed to respond to treatment with the new drug.

22 Jul 2010

New era of scientific innovation to drive novel ways of treating, preventing HIV

The unwillingness of the global AIDS community to accept the status quo is fuelling a new era of scientific innovation to drive novel ways of treating and preventing HIV, organizers of the XVIII International AIDS Conference taking place in Vienna, Austria said today. And, with millions of lives dependent on expanding access to antiretroviral treatment to all those clinically in need, researchers and clinicians are partnering in new ways to find the most effective and efficient methods to deliver treatment and strengthen health systems.

22 Jul 2010

AIDS 2010 studies, releases: PMTCT, treating children, male circumcision; National prevention programs; IDUs

"In parts of Africa, only about half of babies born to mothers with HIV receive the HIV prevention drug nevirapine," according to a study published Wednesday, HealthDay News/U.S. News & World Report reports.

22 Jul 2010

AIDS 2010: Number of HIV positive patients on arvs grew to 5.2m in 2009 with 10m still in need, who says

"The number of HIV-positive people receiving antiretroviral drugs [ARVs] for their infections jumped by more than a quarter in 2009, growing from 4 million to 5.2 million, the World Health Organization said Monday at the International AIDS Conference in Vienna," the Los Angeles Times reports (7/19).

21 Jul 2010

AVAC applauds CAPRISA 004 microbicide gel trial for preventing sexual transmission of HIV infection

"This is a historic day for HIV prevention research. The CAPRISA 004 results are the first clinical evidence that a microbicide gel can help to prevent sexual transmission of HIV infection," said AVAC Executive Director Mitchell Warren, reacting to the results of the landmark microbicide trial presented today at the International AIDS Conference in Vienna.

20 Jul 2010

Bill Gates calls for renewed focus on reducing new HIV infections

Speaking to the 18th International AIDS Conference today, Bill Gates called on all countries to keep up the fight against HIV/AIDS, saying the world has an historic opportunity to "change the face of AIDS." Mr. Gates said current efforts to treat people with HIV are saving millions of lives, and urged a renewed focus on reducing annual new HIV infections up to 90% by 2031, the year that will mark 50 years of the AIDS epidemic.

20 Jul 2010

Scientists find major shortcomings in assessing CVD risk in HIV patients

At the same time that medical science has nearly eliminated AIDS deaths in patients treated for human immunodeficiency virus, two international meetings of HIV/AIDS scientists and patient advocates find major shortcomings in the design and analysis of studies used to assess cardiovascular disease risk in people with HIV with significant implications for improving medical care.

20 Jul 2010

AIDS 2010 opens: Leaders weigh in on global HIV/AIDS funding; Clinton, Gates on efficiency

The six-day International AIDS Conference-AIDS 2010 kicked off Sunday in Vienna, Austria "amid resurgent fears that advances in the 29-year war against the disease were threatened by a slump in funding," Agence France-Presse reports.

20 Jul 2010

A look into HIV related issues

According to a report from US health officials, the poorer neighborhoods of America's cities harbour at least 1 in 50 heterosexual adults infected with HIV. These figures are more than elsewhere in the country. According to the research team from the U.S. Centers for Disease Control and Prevention (CDC), being poor and getting HIV are linked and this was regardless of race or ethnicity.

19 Jul 2010

Phase II data on Genetic Immunity's DermaVir vaccine to be presented at XVIII International AIDS Conference

Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine-based immunotherapies for HIV/AIDS and other chronic diseases, is releasing Phase II data on the Company's novel DermaVir therapeutic vaccine for HIV/AIDS during the XVIII International AIDS Conference this week in Vienna, Austria. DermaVir, the first dendritic cell-targeting topical HIV vaccine candidate, employs nanotechnology to induce multi-faceted and long-lived immune responses capable of eliminating HIV infected cells.

19 Jul 2010

Early HIV treatment reduces death, likelihood of TB, study finds

"Early treatment for HIV cuts patients' risk of death by about 75 percent," according to a study conducted in Haiti and published Thursday in the New England Journal of Medicine, Bloomberg Businessweek reports. The study also demonstrated that "early antiretroviral treatment reduces the likelihood of tuberculosis, a leading cause of death among HIV patients, by 50 percent," the news service writes (Aquino, 7/14).

16 Jul 2010

New HIV treatment strategy could reduce HIV-related deaths by 10M in 15 years, UNAIDS says

UNAIDS on Tuesday outlined a new strategy, called "Treatment 2.0," to simplify the provision of HIV treatment and improve global access to antiretrovirals, Reuters reports. The agency says the plan could prevent up to 10 million AIDS-related deaths by 2025 and reduce the number of new HIV infections annually by up to one million, if all people in need receive treatment, according to the news service.

15 Jul 2010

Science special section examines HIV/AIDS in Russia, Ukraine

In a special section in advance of the International AIDS Conference, Science examines the "state of the HIV/AIDS epidemic in Russia and Ukraine, which account for more than 90% of HIV infections in Eastern Europe."

12 Jul 2010

HHS to give states $25 million for HIV drugs; Researchers identify antibodies that may help in AIDS vaccine research

Health and Human Services Secretary Kathleen Sebelius said Thursday "that she would provide $25 million more to help states buy life-saving medications for people with H.I.V. or AIDS. Advocates for patients said the money was not nearly enough to eliminate waiting lists, which have surged to record levels as people have lost health insurance, along with their jobs, and states have cut their budgets. Ms. Sebelius said she was 'reallocating and transferring $25 million in existing resources' to provide medicines for people on waiting lists.

9 Jul 2010

First Edition: July 1, 2010

Today's health policy headlines highlight news about the launch of a government health insurance web site and the start of the high-risk health insurance pools mandated in the health reform law.

1 Jul 2010

Opinions: Canada's role in global health; Drug licensing agreements promote drug access; Funding for USAID, state; Haiti

After outlining the work of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Michel Kazatchkine, the organization's executive director, highlights the role Canada can play in determining "whether the world can overcome AIDS, tuberculosis and malaria" in a Toronto Star opinion piece, noting the upcoming G8 and G20 summits, as well as the Millennium Development Goal meeting later this year.

23 Jun 2010

Nurse-monitored ART found to be as safe, effective as therapy monitored by doctors in South African trial

"HIV drugs can be administered as effectively by nurses as by doctors, a finding that could yield major benefits in the fight against AIDS in Africa," according to a study published online Wednesday in the Lancet, Agence France-Presse reports.

18 Jun 2010

Also in Global Health News: Clinton to Haiti; Global Fund suspends Zambian aid; Ugandan health workers; MDG summit; Rwandan health insurance; HIV drugs in Kenya

Reuters reports that former President Bill Clinton will return to Haiti to "jump-start" the country's post-earthquake reconstruction. Clinton will head the first meeting of Haiti's reconstruction commission, "part of a sorely needed effort to better coordinate international aid efforts, [Prime Minister Jean-Max] Bellerive said." Bellerive hopes the meeting will "establish clear-cut guidelines" for distributing more than $5 billion in aid from 140 countries following the Jan. 12 earthquake (Brown, 6/16).

16 Jun 2010

HIV drugs News and Research

AIDS 2010 studies, releases: Criminalization, discrimination of high-risk groups; Test-and-treat; UNAIDS launches HIV prevention commission

AIDS 2010: Halving HIV/TB co-infection deaths; Financial transaction tax discussed, and more

New HIV drug on the block

New era of scientific innovation to drive novel ways of treating, preventing HIV

AIDS 2010 studies, releases: PMTCT, treating children, male circumcision; National prevention programs; IDUs

AIDS 2010: Number of HIV positive patients on arvs grew to 5.2m in 2009 with 10m still in need, who says

AVAC applauds CAPRISA 004 microbicide gel trial for preventing sexual transmission of HIV infection

Bill Gates calls for renewed focus on reducing new HIV infections

Scientists find major shortcomings in assessing CVD risk in HIV patients

AIDS 2010 opens: Leaders weigh in on global HIV/AIDS funding; Clinton, Gates on efficiency

A look into HIV related issues

Phase II data on Genetic Immunity's DermaVir vaccine to be presented at XVIII International AIDS Conference

Early HIV treatment reduces death, likelihood of TB, study finds

New HIV treatment strategy could reduce HIV-related deaths by 10M in 15 years, UNAIDS says

Science special section examines HIV/AIDS in Russia, Ukraine

HHS to give states $25 million for HIV drugs; Researchers identify antibodies that may help in AIDS vaccine research

First Edition: July 1, 2010

Opinions: Canada's role in global health; Drug licensing agreements promote drug access; Funding for USAID, state; Haiti

Nurse-monitored ART found to be as safe, effective as therapy monitored by doctors in South African trial

Also in Global Health News: Clinton to Haiti; Global Fund suspends Zambian aid; Ugandan health workers; MDG summit; Rwandan health insurance; HIV drugs in Kenya

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News